Many cancers, including myeloma, frequently escape apoptosis through the upregulation of anti-apoptotic proteins such as bcl2, bclxl and Mcl1 [72]; therefore, pyroptosis induction provides an alternate therapeutic option. Here, BCL2 is linked to plasma cell myeloma.